BioAge Labs expands drug discovery platform with data from HUNT Biobank

BioAge Labs (BIOA) announced the launch of an initiative to profile and analyze samples from the HUNT Biobank in Norway. Through its collaboration with Norwegian diagnostics company Age Labs AS, BioAge will profile more than 17,000 individual samples-collected over decades of aging from 6,000+ HUNT participants-to generate millions of molecular readouts. Analyses of these data, coupled with detailed health and clinical outcomes of the participants, will significantly expand the proprietary human aging data that power BioAge’s drug-discovery platform. The Company has exclusive access for the purpose of drug discovery to data generated by the partnership.